Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.07 +15.80%

+$0.46 today

Market cap
$98.28M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 3.54M

Average 1.15M

QTRX Sales of Investments

Cash received from selling or redeeming investments.

Quanterix CorporationNASDAQ: QTRX

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments declines year over year

Q1 FY2026 sales of investments of $25.35M fell 65.4% year over year, behind the -35.6% change in trailing-twelve-month sales of investments. Sequentially, it fell 21.9% from the prior quarter.

Context

  • Sales of investments amounted to 155.7% of revenue in FY2025, down 4.3 pp from a year earlier.
  • Sales of investments increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth recovers from -65.4% toward the trailing-twelve-month pace of -35.6%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$25.35M-21.9% QoQ
Last fiscal yearDec 2025
$215.83M-0.4% YoY
LTMMar 2026
$167.92M-35.6% YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-65.4%——
1 year-0.4%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
215.83M USD
Year-over-year change
-0.4%

Sales of Investments vs competitors

How QTRX compares with its peers on the latest reported figures

  • QTRX's LTM Mar 2026 sales of investments of $167.92M is the largest of the 11 companies compared; the peer median is $13.84M.
  • Its year-over-year change of -35.6% is the 5th highest of 7, against a peer median of -13.8%.
  • Sales of investments amounts to 115.9% of revenue for QTRX, versus a peer median of 5.3%.
QTRX Competitors Peer median
Sales of Investments for QTRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTRXQuanterix CorporationLTM Mar 2026$167.92M -35.6%—115.9%
OMOutset Medical, Inc.LTM Mar 2026$137.57M -42.6%-14.9%117.0%
SENSSenseonics Holdings, Inc.LTM Mar 2026$71.65M +6.3%-28.4%176.0%
MASS908 Devices Inc.LTM Mar 2026$59.32M +19.4%—102.6%
NNOXNano-X Imaging Ltd.LTM Dec 2025$35.69M -13.3%+2.7%274.1%
INGNInogen, Inc.LTM Mar 2026$18.67M -42.5%+11.8%5.3%
IMRXImmuneering CorporationLTM Mar 2026$9M -14.3%——
SGHTSight Sciences, Inc.LTM Mar 2026$0 ——0.0%
VMDViemed Healthcare, Inc.LTM Mar 2026$0 ——0.0%
CVRXCVRx, Inc.LTM Mar 2026$0 ——0.0%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding QTRX) $13.84M-13.8%-6.1%5.3%

Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(57.69M)(96.7M)(32.33M)(38.53M)(107.15M)
Depreciation & Amortization4.85M5.35M8.38M8.36M18.93M
Deferred Income Tax801K(226K)00(5.87M)
Stock-Based Compensation15.98M15.44M16.76M19.99M20.72M
Change in Working Capital(12.19M)2.07M(11.8M)(18.79M)(2.35M)
Accounts Receivables(6.85M)5.16M(6.7M)(7.7M)10.61M
Inventory(8.09M)5.39M(5.36M)(6.68M)4.03M
Accounts Payables2.41M(5.36M)1.19M723K(528K)
Other Working Capital343K(3.11M)(933K)(5.13M)(16.47M)
Other Non-Cash Items340K25.79M92K(6.19M)(1.51M)
Operating Cash Flow(47.91M)(48.27M)(18.9M)(35.16M)(77.24M)
Capital Expenditures(13.62M)(11.73M)(3.79M)(3.37M)(2.61M)
Acquisitions (Net)0000(93.23M)
Purchases of Investments00(175.61M)(295.61M)(69.76M)
Sales of Investments0031M216.71M215.83M
Other Investing Activities7.28M520K000
Investing Cash Flow(6.34M)(11.21M)(148.4M)(82.27M)50.23M
Debt Repayment(7.74M)0000
Common Stock Issued269.72M2.31M2.89M3.07M738K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities8.82M0(198K)(2.61M)(1.45M)
Financing Cash Flow270.8M2.31M2.69M456K(708K)
Effect of Forex Changes(92K)(538K)301K(734K)1.57M
Net Change in Cash216.46M(57.71M)(164.31M)(117.71M)(26.14M)
Free Cash Flow(61.52M)(60M)(22.69M)(38.53M)(79.85M)

Quanterix Corporation

NASDAQ:QTRX

Intrinsic Alpha fair value

Locked

Current Price

$2.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.